Failure of β-blockers in the reduction of perioperative events: Where did we go wrong?
- 30 November 2006
- journal article
- editorial
- Published by Elsevier in American Heart Journal
- Vol. 152 (5) , 815-818
- https://doi.org/10.1016/j.ahj.2006.08.006
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- The effects of perioperative β-blockade: Results of the Metoprolol after Vascular Surgery (MaVS) study, a randomized controlled trialAmerican Heart Journal, 2006
- ACC/AHA 2006 Guideline Update on Perioperative Cardiovascular Evaluation for Noncardiac Surgery: Focused Update on Perioperative Beta-Blocker TherapyCirculation, 2006
- Perioperative β-blockade (Pobble) for patients undergoing infrarenal vascular surgery: Results of a randomized double-blind controlled trialJournal of Vascular Surgery, 2005
- Statins decrease perioperative cardiac complications in patients undergoing noncardiac vascular surgeryJournal of the American College of Cardiology, 2005
- Fluvastatin and bisoprolol for the reduction of perioperative cardiac mortality and morbidity in high-risk patients undergoing non-cardiac surgery: Rationale and design of the DECREASE-IV studyAmerican Heart Journal, 2004
- Are the recommendations to use perioperative -blocker therapy in patients undergoing noncardiac surgery based on reliable evidence?CMAJ : Canadian Medical Association Journal, 2004
- Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trialPublished by Elsevier ,2004
- Lipid-Lowering Therapy and In-Hospital Mortality Following Major Noncardiac SurgeryJAMA, 2004
- The diabetic postoperative mortality and morbidity (DIPOM) trial: rationale and design of a multicenter, randomized, placebo-controlled, clinical trial of metoprolol for patients with diabetes mellitus who are undergoing major noncardiac surgeryAmerican Heart Journal, 2004
- Cocaine-Related Aortic Dissection in PerspectiveCirculation, 2002